Skip to main content

Featured

A Canadian Dividend Stock Is Leaving Canada — What Algonquin Power's US Move Means for Your RRSP and TFSA

  Published August 9, 2026 Algonquin Power's move to Delaware could change how your dividends are taxed — and whether index funds keep holding the stock at all. If you've owned Algonquin Power & Utilities Corp. (TSX/NYSE: AQN) in your RRSP or TFSA for the dividend, pay attention this week. On Friday, August 7, the Oakville, Ontario-based utility announced it plans to leave Canada — reincorporating as a Delaware company with its head office moving to Chicago. It's not a rumour or a boardroom leak. It came straight from the company's own Q2 2026 earnings release, and CEO Rod West was blunt about the reasoning: more than 80% of Algonquin's operations are now in the United States, with less than 5% left in Canada. The plan is to align the corporate address with where the business actually lives. What's actually changing Here's the plan as Algonquin has laid it out: The company would formally "continue" out of Canada and reincorporate in Delaware,...

article

Provincial Directive Curbs AHS Authority Over Private Surgical Contract Negotiations

 


In a significant policy shift, Alberta Health Minister Adriana LaGrange has stripped Alberta Health Services (AHS) of its authority to negotiate contracts with private surgical facilities. According to a government directive obtained by media, the change came after internal concerns—raised by the agency’s then-chief executive—over rising contract costs.

Documents, including a letter from former AHS CEO Athana Mentzelopoulos’s lawyer, allege that senior government officials—even involving Premier Danielle Smith’s former chief of staff—intervened in AHS’s procurement process to favor private companies. This interference reportedly undermined AHS’s established negotiation powers and raised serious questions about transparency in the province’s health system. 

A separate report in a Morning Update from Unpublished Newswire reiterated the move, noting that the directive is part of broader reforms aimed at reducing costs by leveraging competitive pricing in surgical services.  Meanwhile, a CityNews investigation has added context to the controversy, citing denials by private surgical providers who label the allegations of sweetheart deals as “false and baseless.” 

Critics and opposition leaders are calling for further inquiry into the decision-making process behind these changes, arguing that the shift could signal a move toward greater privatization of public health services. In contrast, government representatives insist that the directive is intended solely to improve efficiency and ensure more competitive pricing for publicly funded operations.

Comments